Clinical Trial Update: PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 study examining the pharmacokinetics of mycophenolate mofetil in cadaveric versus living donor liver transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: University of Rochester | Conditions: Transplantation, Liver | Phase 4 | Status: COMPLETED